Affymax (OTCMKTS:AFFY) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

Posted by on Feb 20th, 2026

Affymax Inc. (OTCMKTS:AFFY – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0010. Affymax shares last traded at $0.0010, with a volume of 10,135 shares traded.

Affymax Stock Up 25.0%

Affymax Company Profile

(Get Free Report)

Affymax, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare and underserved diseases. The company leverages its proprietary TransCon® drug delivery platform to create prodrugs that offer sustained, predictable release of active pharmaceutical ingredients. Affymax’s research efforts concentrate on endocrinology and nephrology indications, seeking to address conditions that currently have limited treatment options.

Among its lead product candidates, Affymax is advancing TransCon® PTH for the treatment of hypoparathyroidism and TransCon® Growth Hormone (TransCon® GH) for pediatric growth hormone deficiency.

Featured Stories

Receive News & Ratings for Affymax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymax and related companies with MarketBeat.com's FREE daily email newsletter.